Complementary anti-inflammatory actions of the β2-adrenoceptor agonist clenbuterol and the glucocorticoid dexamethasone in rat brain

Journal of Neuroimmunology

Volumn 232, Issue 1-2, 2011, Pages 209-216

  Ryan, Katie J ^a   Griffin, Eadaoin W ^a   Connor, Thomas J ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

2 Adrenoceptor; Anti inflammatory; Clenbuterol; Cytokine; Dexamethasone; NF B

Indexed keywords

CLENBUTEROL; DEXAMETHASONE; I KAPPA B ALPHA; I KAPPA B BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; MESSENGER RNA; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BINDING AFFINITY; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DNA BINDING; DRUG EFFICACY; GENE EXPRESSION; HIPPOCAMPUS; MALE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; RAT;

ADRENERGIC BETA-AGONISTS; ANIMALS; ANTI-INFLAMMATORY AGENTS; BRAIN; CLENBUTEROL; CYTOKINES; DEXAMETHASONE; DRUG SYNERGISM; GENE EXPRESSION; INTERLEUKIN-1; INTERLEUKIN-10; MALE; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 79952248058     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.10.001     Document Type: Article

References (56)

1. Allan S.M., Tyrrell P.J., Rothwell N.J. Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 2005, 5:629-640.
2. Arend W.P. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev. 2002, 13:323-340.
3. Arimoto T., Bing G. Up-regulation of inducible nitric oxide synthase in the substantia nigra by lipopolysaccharide causes microglial activation and neurodegeneration. Neurobiol. Dis. 2003, 12:35-45.
4. Arimoto T., Choi D.Y., Lu X., Liu M., Nguyen X.V., Zheng N., Stewart C.A., Kim H.C., Bing G. Interleukin-10 protects against inflammation-mediated degeneration of dopaminergic neurons in substantia nigra. Neurobiol. Aging 2007, 28:894-906.
5. Auphan N., DiDonato J.A., Rosette C., Helmberg A., Karin M. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 1995, 270:286-290.
6. Bachis A., Colangelo A.M., Vicini S., Doe P.P., De Bernardi M.A., Brooker G., Mocchetti I. Interleukin-10 prevents glutamate-mediated cerebellar granule cell death by blocking caspase-3-like activity. J. Neurosci. 2001, 21:3104-3112.
7. Baker B.J., Akhtar L.N., Benveniste E.N. SOCS1 and SOCS3 in the control of CNS immunity. Trends Immunol. 2009, 30:392-400.
8. Baronti A., Grieco A., Vibelli C. Oral NAB 365 (clenbuterol) and terbutaline in chronic obstructive lung disease: a double-blind, two-week study. Int. J. Clin. Pharmacol. Ther. Toxicol. 1980, 18:21-25.
9. Berlato C., Cassatella M.A., Kinjyo I., Gatto L., Yoshimura A., Bazzoni F. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation. J. Immunol. 2002, 168:6404-6411.
10. Bessis N., Guéry L., Mantovani A., Vecchi A., Sims J.E., Fradelizi D., Boissier M.C. The type II decoy receptor of IL-1 inhibits murine collagen-induced arthritis. Eur. J. Immunol. 2000, 30:867-875.
11. Bethea J.R., Nagashima H., Acosta M.C., Briceno C., Gomez F., Marcillo A.E., Loor K., Green J., Dietrich W.D. Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J. Neurotrauma 1999, 16:851-863.
12. Block M.L., Zecca L., Hong J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 2007, 8:57-69.
13. Boner A.L., Vallone G., Brighenti C., Schiassi M., Miglioranzi P., Richelli C. Comparison of the protective effect and duration of action of orally administered clenbuterol and salbutamol on exercise-induced asthma in children. Pediatr. Pulmonol. 1988, 4:197-200.
14. Boyd Z.S., Kriatchko A., Yang J., Agarwal N., Wax M.B., Patil R.V. Interleukin-10 receptor signaling through STAT-3 regulates the apoptosis of retinal ganglion cells in response to stress. Invest. Opthalmol. Vis. Sci. 2003, 44:5206-5211.
15. Boyle N.T., Connor T.J. MDMA ("Ecstasy") suppresses the innate IFN-γ response in vivo: a critical role for the anti-inflammatory cytokine IL-10. Eur. J. Pharmacol. 2007, 572:228-238.
16. Brown G.C., Neher J.J. Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol. Neurobiol. 2010, 41:242-247.
17. Carter D.B., Deibel M.R., Dunn C.J., et al. Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature 1990, 344:633-638.
18. Castaño A., Herrera A.J., Cano J., Machado A. The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh-TNF-alpha, IL-1beta and IFN-gamma. J. Neurochem. 2002, 81:150-157.
19. Chao C.C., Hu S., Close K., Choi C.S., Molitor T.W., Novick W.J., Peterson P.K. Cytokine release from microglia: differential inhibition by pentoxifylline and dexamethasone. J. Infect. Dis. 1992, 166:847-853.
20. Colotta F., Dower S.K., Sims J.E., Mantovani A. The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1. Immunol. Today 1994, 15:562-566.
21. 2-adrenoceptor agonist clenbuterol in vitro and in vivo: evidence from an NGF-antisense study. Neurochem. Int. 1999, 35:47-57.
22. Culmsee C., Stumm R.K., Schäfer M.K., Weihe E., Krieglstein J. Clenbuterol induces growth factor mRNA, activates astrocytes, and protects rat brain tissue against ischemic damage. Eur. J. Pharmacol. 1999, 379:33-45.
23. de Bilbao F., Arsenijevic D., Moll T., Garcia-Gabay I., Vallet P., Langhans W., Giannakopoulos P. In vivo over-expression of interleukin-10 increases resistance to focal brain ischemia in mice. J. Neurochem. 2009, 110:12-22.
24. Docagne F., Campbell S.J., Bristow A.F., Poole S., Vigues S., Guaza C., Perry V.H., Anthony D.C. Differential regulation of type I and type II interleukin-1 receptors in focal brain inflammation. Eur. J. Neurosci. 2005, 21:1205-1214.
25. Donnelly R.P., Dickensheets H., Finbloom D.S. The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. J. Interferon Cytokine Res. 1999, 19:563-573.
26. Ericsson A., Liu C., Hart R.P., Sawchenko P.E. Type 1 interleukin-1 receptor in the rat brain: distribution, regulation, and relationship to sites of IL-1-induced cellular activation. J. Comp. Neurol. 1995, 361:681-698.
27. 2-adrenoceptor agonist clenbuterol elicits neuroprotective, anti-inflammatory and neurotrophic actions in the kainic acid model of excitotoxicity. Brain Behav. Immun. 2010, 24:1354-1361.
28. Heneka M.T., O'Banion M.K. Inflammatory processes in Alzheimer's disease. J. Neuroimmunol. 2007, 184:69-91.
29. Hertz L., Chen Y., Gibbs M.E., Zang P., Peng L. Astrocytic adrenoceptors: a major drug target in neurological and psychiatric disorders?. Curr. Drug Targets CNS Neurol. Disord. 2004, 3:239-267.
30. Junker V., Becker A., Hühne R., Zembatov M., Ravati A., Culmsee C., Krieglstein J. Stimulation of beta-adrenoceptors activates astrocytes and provides neuroprotection. Eur. J. Pharmacol. 2002, 446:25-36.
31. Kimberlin D.W., Willis S.A., McCracken G.H., Nisen P.D. Protein synthesis-dependent induction of interleukin-1β by lipopolysaccharide is inhibited by dexamethasone via mRNA destabilization in human astroglial cells. J. Clin. Immunol. 1995, 15:199-204.
32. Knudsen P.J., Dinarello C.A., Strom T.B. Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells. J. Immunol. 1987, 139:4129-4134.
33. Ledeboer A., Brevé J.J., Poole S., Tilders F.J., Van Dam A.M. Interleukin-10, interleukin-4, and transforming growth factor-beta differentially regulate lipopolysaccharide-induced production of pro-inflammatory cytokines and nitric oxide in co-cultures of rat astroglial and microglial cells. Glia 2000, 30:134-142.
34. Li Y., Chu N., Rostami A., Zhang G.X. Dendritic cells transduced with SOCS-3 exhibit a tolerogenic/DC2 phenotype that directs type 2 Th cell differentiation in vitro and in vivo. J. Immunol. 2006, 177:1679-1688.
35. McNamee E.N., Griffin E.W., Ryan K.M., Ryan K.J., Heffernan S., Harkin A., Connor T.J. Noradrenaline acting at beta-adrenoceptors induces expression of IL-1beta and its negative regulators IL-1ra and IL-1RII, and drives an overall anti-inflammatory phenotype in rat cortex. Neuropharmacology 2010, 59:37-48.
36. McNamee E.N., Ryan K.M., Griffin E.W., González-Reyes R.E., Ryan K.J., Harkin A., Connor T.J. Noradrenaline acting at central beta-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain: Implications for neurodegeneration. Brain Behav. Immun. 2010, 24:660-671.
37. McNamee E.N., Ryan K.M., Kilroy D., Connor T.J. Noradrenaline induces IL-1ra and IL-1 type II receptor expression in primary glial cells and protects against IL-1beta-induced neurotoxicity. Eur. J. Pharmacol. 2010, 626:219-228.
38. Molina-Holgado F., Grencis R., Rothwell N.J. Actions of exogenous and endogenous IL-10 on glial responses to bacterial LPS/cytokines. Glia 2001, 33:97-106.
39. Mozo L., Suárez A., Gutiérrez C. Glucocorticoids up-regulate constitutive interleukin-10 production by human monocytes. Clin. Exp. Allergy 2004, 34:406-412.
40. Nishida T., Nakai S., Kawakami T., Aihara K., Nishino N., Hirai Y. Dexamethasone regulation of the expression of cytokine mRNAs induced by interleukin-1 in the astrocytoma cell line U373MG. FEBS Lett. 1989, 243:25-29.
41. Papiris S., Galavotti V., Sturani C. Effects of beta-agonists on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease. Respiration 1986, 49:101-108.
42. Park K.W., Lee H.G., Jin B.K., Lee Y.B. Interleukin-10 endogenously expressed in microglia prevents lipopolysaccharide-induced neurodegeneration in the rat cerebral cortex in vivo. Exp. Mol. Med. 2007, 39:812-819.
43. Qin H., Wilson C.A., Roberts K.L., Baker B.J., Zhao X., Benveniste E.N. IL-10 inhibits lipopolysaccharide-induced CD40 gene expression through induction of suppressor of cytokine signaling-3. J. Immunol. 2006, 177:7761-7771.
44. Qin H., Niyongere S.A., Lee S.J., Baker B.J., Benveniste E.N. Expression and functional significance of SOCS-1 and SOCS-3 in astrocytes. J. Immunol. 2008, 181:3167-3176.
45. Quan N., He L., Lai W., Shen T., Herkenham M. Induction of IkappaBalpha mRNA expression in the brain by glucocorticoids: a negative feedback mechanism for immune-to-brain signaling. J. Neurosci. 2000, 20:6473-6477.
46. Raghavendra Rao V.L., Bowen K.K., Dhodda V.K., Song G., Franklin J.L., Gavva N.R., Dempsey R.J. Gene expression analysis of spontaneously hypertensive rat cerebral cortex following transient focal cerebral ischemia. J. Neurochem. 2002, 83:1072-1086.
47. Saito M., Watanabe S. Differential modulation of lipopolysaccharide- and zymosan-induced hypophagia by dexamethasone treatment. Pharmacol. Biochem. Behav. 2008, 90:428-433.
48. Scheinman R.I., Cogswell P.C., Lofquist A.K., Baldwin A.S. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 1995, 270:283-286.
49. Semkova I., Schilling M., Henrich-Noack P., Rami A., Krieglstein J. Clenbuterol protects mouse cerebral cortex and rat hippocampus from ischemic damage and attenuates glutamate neurotoxicity in cultured hippocampal neurons by induction of NGF. Brain Res. 1996, 717:44-54.
50. Slotkin T.A., Lau C., McCook E.C., Lappi S.E., Seidler F.J. Glucocorticoids enhance intracellular signaling via adenylate cyclase at three distinct loci in the fetus: a mechanism for heterologous teratogenic sensitization?. Toxicol. Appl. Pharmacol. 1994, 127:64-75.
51. Starr R., Willson T.A., Viney E.E. A family of cytokine-inducible inhibitors of signalling. Nature 1997, 387:917-921.
52. Ting A.Y., Endy D. Signal transduction. Decoding NF-kappaB signaling. Science 2002, 298:1189-1190.
53. Velasco S., Tarlow M., Olsen K., Shay J.W., McCracken G.H., Nisen P.D. Temperature-dependent modulation of lipopolysaccharide-induced interleukin-1β and tumor necrosis factor-α expression in cultured human astroglial cells by dexamethasone and indomethacin. J. Clin. Invest. 1991, 87:1674-1680.
54. Xia C.Q., Peng R., Beato F., Clare-Salzler M.J. Dexamethasone induces IL-10-producing monocyte-derived dendritic cells with durable immaturity. Scand. J. Immunol. 2005, 62:45-54.
55. Zhou Z., Peng X., Insolera R., Fink D.J., Mata M. Interleukin-10 provides direct trophic support to neurons. J. Neurochem. 2009, 110:1617-1627.
56. Zhu Y., Culmsee C., Semkova I., Krieglstein J. Stimulation of beta2-adrenoceptors inhibits apoptosis in rat brain after transient forebrain ischemia. J. Cereb. Blood Flow Metab. 1998, 18:1032-1039.